Skip to main content
GANX logo

GANX

Gain Therapeutics, Inc.
$1.91 -0.08 (-4.02%) At close · Jul 2
Market Cap
$81.47M
Shares
42,654,038

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 42
Total Value: $16,136,507
Total Shares: 8,317,799

Institutional Ownership Trend

21 quarters

Holder Concentration

Across 42 13F filers · Δ vs Dec 31, 2025
Top Holder
21.3%
Jun 2023 → Mar 2026 · range 15.6% – 41.4%
+1.0 pts
Top 5
54.6%
Jun 2023 → Mar 2026 · range 54.6% – 83.2%
−2.5 pts
Top 10
77.3%
Jun 2023 → Mar 2026 · range 77.3% – 96.4%
−4.1 pts
HHI
898
Jun 2023 → Mar 2026 · range 834 – 2,039
Broadly held−24

Quarterly Activity

vs Dec 31, 2025
New
9
Increased
10
Decreased
10
Sold Out
16
Unchanged
13
Holder count: -7
Institutional value: -38.7%
Shares held: +1.7%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 46 of 46
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1819411 CUSIP 36269B105 Visit website Investor relations